These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
991 related articles for article (PubMed ID: 27476966)
1. Midbrain-like Organoids from Human Pluripotent Stem Cells Contain Functional Dopaminergic and Neuromelanin-Producing Neurons. Jo J; Xiao Y; Sun AX; Cukuroglu E; Tran HD; Göke J; Tan ZY; Saw TY; Tan CP; Lokman H; Lee Y; Kim D; Ko HS; Kim SO; Park JH; Cho NJ; Hyde TM; Kleinman JE; Shin JH; Weinberger DR; Tan EK; Je HS; Ng HH Cell Stem Cell; 2016 Aug; 19(2):248-257. PubMed ID: 27476966 [TBL] [Abstract][Full Text] [Related]
2. High-throughput generation of midbrain dopaminergic neuron organoids from reporter human pluripotent stem cells. Sarrafha L; Parfitt GM; Reyes R; Goldman C; Coccia E; Kareva T; Ahfeldt T STAR Protoc; 2021 Jun; 2(2):100463. PubMed ID: 33997803 [TBL] [Abstract][Full Text] [Related]
3. Neural Differentiation in the Third Dimension: Generating a Human Midbrain. Marton RM; Paşca SP Cell Stem Cell; 2016 Aug; 19(2):145-146. PubMed ID: 27494668 [TBL] [Abstract][Full Text] [Related]
5. Carbon Fibers as a New Type of Scaffold for Midbrain Organoid Development. Tejchman A; Znój A; Chlebanowska P; Frączek-Szczypta A; Majka M Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32825046 [TBL] [Abstract][Full Text] [Related]
6. Generation of Human Ventral Midbrain Organoids Derived from Pluripotent Stem Cells. Sozzi E; Nilsson F; Kajtez J; Parmar M; Fiorenzano A Curr Protoc; 2022 Sep; 2(9):e555. PubMed ID: 36121202 [TBL] [Abstract][Full Text] [Related]
7. A fully automated high-throughput workflow for 3D-based chemical screening in human midbrain organoids. Renner H; Grabos M; Becker KJ; Kagermeier TE; Wu J; Otto M; Peischard S; Zeuschner D; TsyTsyura Y; Disse P; Klingauf J; Leidel SA; Seebohm G; Schöler HR; Bruder JM Elife; 2020 Nov; 9():. PubMed ID: 33138918 [TBL] [Abstract][Full Text] [Related]
8. Use of 3D Organoids as a Model to Study Idiopathic Form of Parkinson's Disease. Chlebanowska P; Tejchman A; Sułkowski M; Skrzypek K; Majka M Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 31973095 [TBL] [Abstract][Full Text] [Related]
9. From 2D to 3D: Development of Monolayer Dopaminergic Neuronal and Midbrain Organoid Cultures for Parkinson's Disease Modeling and Regenerative Therapy. Yeap YJ; Teddy TJW; Lee MJ; Goh M; Lim KL Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768843 [TBL] [Abstract][Full Text] [Related]
11. Neural stem cells derived from human midbrain organoids as a stable source for treating Parkinson's disease: Midbrain organoid-NSCs (Og-NSC) as a stable source for PD treatment. Kim SW; Woo HJ; Kim EH; Kim HS; Suh HN; Kim SH; Song JJ; Wulansari N; Kang M; Choi SY; Choi SJ; Jang WH; Lee J; Kim KH; Lee W; Kim SH; Yang J; Kyung J; Lee HS; Park SM; Chang MY; Lee SH Prog Neurobiol; 2021 Sep; 204():102086. PubMed ID: 34052305 [TBL] [Abstract][Full Text] [Related]
12. Precision Medicine in Parkinson's Disease Using Induced Pluripotent Stem Cells. Kim MS; Kim H; Lee G Adv Healthc Mater; 2024 Aug; 13(21):e2303041. PubMed ID: 38269602 [TBL] [Abstract][Full Text] [Related]